The gain of apolipoprotein e genotyping to separate patients with alzheimer’s disease from normal individuals: Relevance to community studies

Dementia and Geriatric Cognitive Disorders

Volumn 7, Issue 6, 1996, Pages 336-342

  Frisoni, Giovanni B ^a   Geroldi, Cristina ^a   Bianchetti, Angelo ^a   Binetti, Giuliani ^a   Trabucchi, Marco ^a  

^a GERIATRIC RESEARCH GROUP   (Italy)

Author keywords

Alzhimer disease; Apolipoprotein E; Case finding; Epidemiology; Screening studies

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DISCRIMINANT ANALYSIS; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING TEST;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COMMUNITY MEDICINE; DISCRIMINANT ANALYSIS; FEMALE; GENOTYPE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REFERENCE VALUES;

EID: 0029820111     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000106900     Document Type: Article

References (31)

1. Farrcr L: Siaiemcnt on the use of apolipopro-tcin E testing for Alzheimer disease. JAMA 1995;274:1627-1629.
2. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, Kokmcn E, Waring SC, Kurland LT: Apolipoprotcin Estatus as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-1278.
3. Tierney MC, Szalai JP, Snow WG, Fisher RH, Tsuda T, Chi H, McLachlan DR, St Gcorgc-Hyslop PH: A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology 1996;46:149-154.
4. Roses AD: Apolipoprotcin E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995:38:6-14.
5. Frisoni GB, Bianchetti A, Govoni S, Trabucchi M: Diagnostic usefulness of apolipoprotcin E s4 in the diagnosis of the dementias. J Neurol Neurosurg Psychiatry 1996;60:699-700.
6. Van Gool WA, Hijdra A: Diagnosis of Alzheimer’s disease by apolipoprotein E genotyping. Lancet 1994;344:275.
7. Prince MJ: Predicting the onset of Alzheimer's disease using Bayes' theorem. Am J Epidemiol 1996:143:301-308.
8. Folstein M, Folstcin S, McHugh P: The Mini-Mental State Examination. J Psychiatr Res 1975;I2:I89-19S.
9. Rocca WA, Bonaiuto S, Lippi A, Luciani P, Turtu F, Cavarzcran F, Amaducci L: Validation of the I lodgkinson abbreviated mental test in Appignano, Macerata Province, Italy: in Dewey ME, Copeland JRM, Hofman A (eds): Case Finding for Dementia in Epidemiological Studies. Liverpool, Institute of Human Ageing. University of Liverpool. 1990. pp 23-31.
10. Black SE, Blessed G, Edwardson JA, Kay DW: Prevalence rates of dementia in an ageing population: Are low rates due to the use of insensitive instruments? Age Ageing 1990; 19:84-90.
11. Kay DWK, Henderson AS, Scott R: Dementia and depression among the elderly living in the Hobart community: The effect of the diagnostic criteria on the prevalence rates. Psychol Med 1985;15:771-788.
12. Tombaugh TN, McIntyre NJ: The Mini-Mental State Examination: A comprehensive review. J Am GeriatrSoc 1992;40:922-935.
13. Roses AD, Striltmattcr WJ, Pericack-Vancc MA, Cordcr EH, Saunders AM, Schmcchcl DE: Clinical application of apolipoprotcin E genotyping to Alzheimer’s disease. Lancet 1994,344:275.
14. Brodaty H: Consensus statement on predictive testing for Alzheimer disease. Alzheimer Dis Assoc Disord 1995;9:182-187.
15. McKhann G, Drachman D, Folstcin M, Katz-man R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 1984:34:939-944.
16. Brun A. Englund B. Gustafson L. Passant U. Mann DMA. Neary D. Snowden J: Clinical and neuropathological criteria for fromotcm-poral dementia. J Neurol Neurosurg Psychiatry 1994;57:416-418.
17. McKcith IG. Fairbairn AF. Bothwell RA. Moore PB. Fcrricr IN. Thompson P. Perry RH: An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994:44:872-877.
18. Knopman DS. Christensen KJ. Schut U. Har-baugh RE. Reeder T. Ngo T. Frey W: The spectrum of imaging and neuropsychological findings in Pick's disease. Neurology 1989;39:362-368.
19. Frisoni GB, Govoni S, Geroldi C, Bianchetti A, Calabresi L, Franceschini G, Trabucchi M: Gene dose of the e4 allele of apolipoprotcin E and gender in sporadic late-onsct Alzheimer's disease. Ann Neurol 1995;37:596-604.
20. Kohlmcicr M. Drossel H. Sinha P. Kottgen E: Rapid and simple method for the identification of apoE isomorphic phenotype from whole serum. Electrophoresis 1992:13:258-263.
21. Kohlmcicr M. Drossel H. Sinha P. Kottgen E Statistical Package for the Social Sciences. Rel 5.0. Chicago. 1992.
22. Kahn HA, Scmpos CT: Statistical Methods in Epidemiology. New York, Oxford University Press. 1959. pp 72-84.
23. Cordcr EH. Saunders AM. Strittmatter WJ. Schmechcl DE, Gaskell PC, Small GV, Roses AD, Haines JL, Pcricak-Vancc M A: Gene dose of apolipoprolein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993:261:921-923.
24. Saunders AM. Strittmatter WJ. Schmcchel D, St Gcorge-Hvslop PH, Pericak-Vancc MA, Joo SH. Rosi BL. Gusella JF. Crapper-MacLachlan DR. Alberts MJ. Hulelle C. Crain B. Goldga-bcr D. Roses AD: Association of apolipopro-tein E allele e4 with lale-onsel familial and sporadic Alzheimer's disease. Neurology 1993:43: 1467-1472.
25. Bird ID: Apolipoprotcin E genotyping in the diagnosis of Alzheimer's disease. Ann Neurol 1995;38:2-5.
26. Myers RH, Schaefer EJ. Wilson PWF. D'Agostino R, Ordovas JM. Espino A, Au R. White RF. Knocfel JE. Cobb JL. McNulty KA. Beiser A. Wolf PA: Apolipoprotcin E e4 association with dementia in a population-based study: The Framingham study. Neurology 1996;46: 673-677.
27. Frisoni GB. Calabresi L. Geroldi C. Bianchetti A. D'Acquarica AL. Covoni S, Sirtori CR, Trabucchi M. Franccschini G: Apolipoprolein Ee4allele in Alzheimer’s disease and vascular dementia. Dementia 1994:5:240-242.
28. Treves TA, Asherov A, Chapman J. Verchovs-ky R. KJimovitzky S. Morduchowicz M. Korc-zyn AD: ApoE haplotypes in vascular dementia. Neurology 1995:45:S469.
29. Shimano H, Ishibashi S, Murase T, Gotohda T, Yamada N, Takaku F, Ohtomo E: Plasma apo-lipoprotcins in patients with multi-infarct dementia. Atherosclerosis 1989:79:257-260.
30. St Clair D. Norrman J. Perry R. Yates C. Wil-cock G. Brookes A: Apolipoprotcin E e4 allele frequency in patients with Lewy body dementia, Alzheimer’s disease and age-matched controls. Neurosci Lett 1994;176:45-46.
31. Harrington CR, Louwagic J, Rossau R, Van-mcchclcn E, Pcrrv RH, Perry EK, Xuereb JI, Roth M, Wischik CM: Influence of apolipopro-tein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol 1994:145:1472-1484.